Exposure of a Distinct PDCA-1+ (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Vinay, Dass S ^a   Lee, Seung J ^b   Kim, Chang H ^b   Oh, Ho Sik ^b   Kwon, Byoung S ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD137 ANTIGEN; CD137 MONOCLONAL ANTIBODY; CD86 ANTIGEN; CELL PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; OVALBUMIN; PROTEIN P70; PROTEIN PD L2; RANTES; THYMUS DEPENDENT ANTIGEN; THYMUS INDEPENDENT ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL TRANSFORMATION; CONTROLLED STUDY; EXPOSURE; GENE REARRANGEMENT; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PDCA 1+ B CELL; PLASMACYTOID DENDRITIC CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD137; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIVISION; CELL LINEAGE; CYTOKINES; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN CLASS SWITCHING; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; PROTEIN ISOFORMS; T-LYMPHOCYTES;

EID: 84869754889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050272     Document Type: Article

References (43)

1. Kwon BS, Weissman SM, (1989) cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 86: 1963-1967.
2. Watts TH, (2005) The TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23: 23-68.
3. Croft M, (2003) Costimulation of T cells by OX-40, 4-1BB, and CD27. Cytokine Growth Factor Rev 14: 265-273.
4. Wilcox RA, Chapoval AI, Gorski KS, Otsuji M, Shin T, et al. (2002) Expression of functional CD137 receptor by dendritic cells. J Immunol 2002 168: 4262-4267.
5. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, et al. (2002) CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
6. Vinay DS, Kwon BS (2006) Genes, transcripts, and proteins of CD137 receptor and ligand. In: Chen, L, editor. CD137 Pathway: Immunology and Diseases. Springer, New York, New York. pp 1-14.
7. Vinay DS, Cha K, Kwon BS, (2006) Dual immunoregulatory pathways of 4-1BB signaling. J Mol Med 84: 726-736.
8. Niu L, Strahotin S, Hewes B, Zhang B, Zhang Y, et al. (2007) Cytokine-mediated disruption of lymphocyte trafficking, hemopoiesis, and induction of lymphopenia, anemia, and thrombocytopenia in anti-CD137-treated mice. J Immunol 178: 4194-4213.
9. Sun Y, Chen HM, Subudhi SK, Chen J, Koka R, et al. (2002) Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med 8: 1405-1413.
10. Vinay DS, Kim JD, Kwon BS, (2006) Amelioration of mercury-induced autoimmunity by 4-1BB. J Immunol 177: 5708-5717.
11. Menoret A, Myers LM, Lee SJ, Mittler RS, Rossi RJ, et al. (2006) TGFβ protein processing and activity through TCR triggering of primary CD8+ T regulatory cells. J Immunol 177: 6091-6097.
12. Myers L, Croft M, Kwon BS, Mittler RS, Vella AT, (2005) Peptide-specific CD8 T regulatory cells use IFN-γ to elaborate TGF-β-based suppression. J Immunol 174: 7625-7632.
13. Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS, (2006) 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Cytokine 34: 233-242.
14. Seo SK, Choi JH, Kim YH, Kang WJ, Park YH, et al. (2004) 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 10: 1088-1094.
15. Vinay DS, Kwon BS, (2011) 4-1BB signaling beyond T cells. Cell Mol Immunol 8: 281-284.
16. McKenna K, Beignon AS, Bhardwaj N, (2005) Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 79: 17-27.
17. GeurtsvanKessel CH, Lambrecht BN, (2008) Division of labor between dendritic cell subsets of the lung. Mucosal Immunol 1: 442-450.
18. Henri S, Vremec D, Kamath A, Waithman J, Williams S, et al. (2001) The dendritic cells populations of mouse lymph nodes. J Immunol 167: 741-748.
19. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, et al. (2004) Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 16: 915-928.
20. Colonna M, Trinchieri G, Liu YJ, (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226.
21. Jongloed SL, Benson RA, Nickdel MB, McInnes IB, Brewer JM, (2009) Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol 182: 963-968.
22. Lund JM, Linehan MM, Iijima N, Iwasaki A, (2006) Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol 177: 7510-7514.
23. Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JAA, Dzionek A, et al. (2008) Central nervous system plasmacytoid dendritic cells regulate severity of relapsing experimental autoimmune encephalomyelitis. J Immunol 180: 6457-6461.
24. Zhang X, Voskens CJ, Sallin M, Maniar A, Montes CL, et al. (2010) CD137 promotes proliferation and survival of human B cells. J Immunol 184: 787-795.
25. Vinay DS, Kim CH, Chang KH, Kwon BS, (2010) PDCA expression by B lymphocytes reveals important functional attributes. J Immunol 184: 807-815.
26. Liu YJ, (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
27. Bao Y, Han Y, Chen Z, Xu S, Cao X, (2011) IFN-α-producing PDCA-1+Siglec-H- B cells mediate innate immune defense by activating NK cells. Eur J Immunol 41: 657-668.
28. Grohman U, Orabona C, Fallarino F, Vacca C, Calcinaro F, et al. (2002) CTLA-4Ig regulates tryptophan catabolism in vivo. Nat Immunol 3: 1097-1101.
29. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, et al. (2010) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in syustemic lupus erythematosus patients. Immunity 32: 129-140.
30. Iwata Y, Matsuhita T, Horikawa M, Dilillo DJ, Yanaba K, et al. (2010) Characterization of a rare IL-10-competent B-cell subunit in humans that parallels mouse regulatory B cells. Blood 117: 530-541.
31. Shriner AK, Liu H, Sun G, Guimond M, Alugupalli KR, (2010) IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumonia. J Immunol 185: 525-531.
32. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, et al. (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 181: 1519-1526.
33. Hao Z, Rajewsky K, (2001) Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 194: 1151-1164.
34. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2: 261-268.
35. Tafuri A, Shanian A, Bladt F, Yoshinaga SK, Jordana M, et al. (2001) ICOS is essential for effective T-helper-cell responses. Nature 409: 105-109.
36. Choi BK, Asai T, Vinay DS, Kim YH, Kwon BS, (2006) 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms. Cytokine 34: 233-242.
37. Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, et al. (2011) B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. Proc Nat Acad Sci USA 108: 10662-10667.
38. Lee SW, Croft M, (2009) 4-1BB as a therapeutic target for human disease. Adv Exp Med Biol 647: 120-129.
39. Schall TJ, Bacon KB, (1994) Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6: 865-873.
40. Schlöndorff D, Nelson PJ, Luckow B, Banas B, (1997) Chemokines and renal disease. Kidney Int 51: 610-621.
41. Schrum S, Probst P, Fleischer B, Zipfel PF, (1996) Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol 157: 3598-3604.
42. Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, et al. (2002) Type I IFN as a natural adjuvant for a protective immune response: lessons from influenza vaccine model. J Immunol 169: 375-383.
43. Sapoznikov A, Fischer JAA, Zaft T, Krauthgamer R, Dzionek A, et al. (2007) Organ-dependent in vivo priming of naïve CD4+ but not CD8+ T cells by plasmacytoid dendritic cells. J Exp Med 204: 1923-1933.